Scarica l'app Stockscreener
2.35
6.82%
-0.18
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
4.3498
|
- | 4.774 | 5.8964 | 5.1796 |
| Operating Income/Loss |
-4.3498
|
- | -4.774 | -5.8964 | -5.1796 |
| Income/Loss From Continuing Operations Before Tax |
3.55%
-4.1774
|
-4.331 | -4.5368 | -5.8752 | -4.5057 |
| Income/Loss From Continuing Operations After Tax |
3.55%
-4.1774
|
-4.331 | -4.5368 | -5.8752 | -4.5057 |
|
Net Income/Loss
|
3.55%
-4.1774
|
-4.331 | -4.5368 | -5.8752 | -4.5057 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10.83
|
- | 10.78 | 0.0073 | 10.76 |
| Diluted Average Shares |
10.83
|
- | 10.78 | 0.0073 | 10.76 |
| Basic Earnings Per Share |
-0.39
|
- | -0.42 | -0.54 | -0.42 |
| Diluted Earnings Per Share |
-0.39
|
- | -0.42 | -0.54 | -0.42 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):